Overview of opportunistic fungal infections in India

Arunaloke Chakrabarti1, Shiv Sekhar Chatterjee, M R Shivaprakash

  • 1Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

Insights

Fungal infections are increasing in immunocompromised patients in India. Improved diagnostics and antifungal strategies are crucial to address the rising burden of opportunistic mycoses like candidiasis and aspergillosis.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Public Health in India

Background:

  • Opportunistic fungal infections (mycoses) are a growing concern in immunocompromised patients within Indian tertiary care centers.
  • India's climate favors diverse fungal pathogens, yet data on mycoses burden is limited, with a lack of awareness among clinicians regarding emerging trends.
  • Existing data suggests an increasing incidence of invasive candidiasis, aspergillosis, and zygomycosis, with unique regional patterns observed.

Purpose of the Study:

  • To highlight the current landscape and challenges of opportunistic mycoses in India.
  • To underscore the need for enhanced diagnostic mycology services and updated clinical awareness.
  • To emphasize the importance of refining antifungal treatment strategies.

Main Methods:

  • Review of existing data on opportunistic fungal infections in Indian tertiary care settings.
  • Analysis of reported trends in specific mycoses, including candidiasis, aspergillosis, and zygomycosis.
  • Assessment of the impact of environmental and clinical factors on fungal disease prevalence.

Main Results:

  • Invasive candidiasis is the most common opportunistic mycosis, with a notable prevalence of Candida tropicalis in candidemia.
  • Invasive aspergillosis is a significant concern, potentially exacerbated by ongoing hospital construction.
  • India reports the world's highest incidence of invasive zygomycosis, often linked to uncontrolled diabetes mellitus.

Conclusions:

  • There is an urgent need for improved diagnostic mycology laboratories and rapid diagnostic capabilities in India.
  • Antiretroviral therapy has not reduced the incidence of cryptococcosis and penicilliosis in AIDS patients.
  • Refinement of antifungal strategies and increased clinical awareness are essential to combat the rising tide of fungal infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...